“Stability Indicating Technique And Validation For Dolutegravir, Lamivudine And Tenofovir Disoproxil Fumarate By UPLC”, Journal of Pharmaceutical Negative Results, pp. 58–63, Jan. 2023, doi: 10.47750/pnr.2023.14.03.08.